CLINICAL_TRIALS
trial_result
· 2026-01-13
Clinical Trial Update: Evaluate the Neurological Effects of EryDex on Subjects With A-T [Phase 3]
Summary
Phase 3 trial evaluating the neurological effects of EryDex in people with Ataxia Telangiectasia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Quince Therapeutics S.p.A. | Conditions: Ataxia Telangiectasia | Phase 3 | Status: COMPLETED